Cancer in Scotland: Action for Change set a target that "by 2005, the maximum wait from urgent referral to treatment for all cancers will be two months"
Colorectal Period of diagnosis: 1 October to 31 December 2006
Area of diagnosis | Number of eligible urgent referrals* | Number treated within 2 months (62 days) of referral | % compliance with 2 month urgent referral to treatment target | Minimum wait (Days) | Maximum wait (Days) | Median wait (Days) | 90th Percentile (Days) |
| | | | | | | |
Scotland | 345 | 278 | 80.6% | 0 | 233 | 38 | 87 |
| | | | | | | |
NOSCAN | 94 | 76 | 80.9% | 0 | 126 | 38 | 80 |
Argyll & Clyde (Highland) | 2 | 2 | 100.0% | 2 | 7 | n/a | n/a |
Grampian | 32 | 26 | 81.3% | 0 | 126 | 26 | 93 |
Highland | 16 | 9 | 56.3% | 1 | 87 | 54 | 82 |
Orkney | - | - | n/a | n/a | n/a | n/a | n/a |
Shetland | 1 | 1 | 100.0% | 49 | 49 | n/a | n/a |
Tayside | 40 | 35 | 87.5% | 0 | 101 | 22 | 70 |
Western Isles | 3 | 3 | 100.0% | 9 | 55 | 39 | n/a |
| | | | | | | |
SCAN | 93 | 68 | 73.1% | 0 | 233 | 36 | 113 |
Borders | 7 | 6 | 85.7% | 2 | 94 | 19 | n/a |
Dumfries & Galloway | 15 | 14 | 93.3% | 2 | 84 | 35 | 68 |
Fife | 17 | 15 | 88.2% | 2 | 84 | 36 | 70 |
Lothian | 54 | 33 | 61.1% | 0 | 233 | 48 | 124 |
| | | | | | | |
WOSCAN | 158 | 134 | 84.8% | 0 | 154 | 38 | 70 |
Argyll & Clyde (Greater Glasgow) | 23 | 22 | 95.7% | 0 | 66 | 23 | 58 |
Ayrshire & Arran | 18 | 15 | 83.3% | 0 | 87 | 52 | 75 |
Forth Valley | 19 | 18 | 94.7% | 0 | 82 | 47 | 62 |
Lanarkshire | 31 | 21 | 67.7% | 0 | 154 | 49 | 138 |
Greater Glasgow | 67 | 58 | 86.6% | 0 | 120 | 32 | 64 |
*Exclusion categories are: died prior to receiving treatment, refused treatment, patient induced non-clinical delay, co-morbidities, clinical reasons and initially referred to another non-cancer speciality.
n/a: Not applicable due to small numbers.
Cancer waiting times statistics are subject to a programme of quality improvement focusing on consistency and coverage.
These improvements need to be taken in to account when making comparisons on quarter on quarter performance.